Lipid Supplements for Mitochondrial Function

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Mitochondrial dysfunction is associated with various chronic degenerative disorders, autoimmune diseases, and aging, and existing nutritional supplements do not effectively address the specific needs of mitochondrial health and organ-specific phospholipid balance, leading to inadequate energy production and increased oxidative stress.

Innovation Solution

Development of novel lipid formulations and Cyanithins enriched with specific phospholipids and fatty acids, combined with caffeine and probiotics, to enhance mitochondrial function, increase nutrient bioavailability, and restore cellular energy by targeting mitochondrial and cellular membranes with tailored lipid profiles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing nutritional supplements are used, then general nutritional support is provided, but mitochondrial function is not effectively restored and oxidative stress increases

Engineering Contradiction:

Improvemitochondrial functionVSAvoidoxidative stress

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by formulating organ-specific phospholipid supplements tailored to the unique lipid composition requirements of different organs. Each organ (heart, brain, liver, kidneys, lungs, muscles) receives a customized phospholipid profile matching its specific membrane composition needs, rather than using generic supplements. This targeted approach restores mitochondrial function in each organ while reducing oxidative stress damage.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent uses composite materials by combining multiple phospholipid species (phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, cardiolipin) with specific fatty acid compositions in defined ratios. These composite phospholipid formulations are designed to replace damaged membrane lipids and restore mitochondrial function more effectively than single-component supplements.

Inventive Principle:

Principle #40Composite materials

2Adaptability or versatility

If generic phospholipid supplements are used, then general membrane support is provided, but organ-specific phospholipid balance is not restored

Engineering Contradiction:

Improveorgan-specific phospholipid balanceVSAvoidphospholipid composition

Core Design Contradiction:

Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent implements local quality by creating distinct phospholipid formulations for each organ based on its specific lipid requirements. For example, cardiac phospholipids contain specific ratios of phosphatidylcholine and phosphatidylserine optimized for heart membrane function, while brain phospholipids contain different ratios suited for neural membranes. This ensures each organ receives the precise phospholipid composition it needs.

Inventive Principle:

Principle #3Local quality

Solution Approach 2:

The patent applies parameter changes by varying the compositional parameters of phospholipid supplements to match organ-specific requirements. Each formulation adjusts the concentrations and ratios of individual phospholipid species and fatty acids according to the target organ's membrane composition, transforming a generic supplement into an organ-specific therapeutic.

Inventive Principle:

Principle #35Parameter changes

3Productivity

If lipid formulations are designed for general health, then broad nutritional support is provided, but mitochondrial energy production is insufficient

Engineering Contradiction:

Improveenergy productionVSAvoidmitochondrial function

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent applies self-service by providing phospholipid substrates that enable mitochondria to self-repair their own membrane structures. The supplements contain the specific phospholipid building blocks that mitochondria need to reconstruct damaged membranes and restore their own function, allowing the cells to service themselves without external intervention.

Inventive Principle:

Principle #25Self-service

Solution Approach 2:

The patent implements preliminary action by providing phospholipid supplements before significant mitochondrial damage occurs or in the early stages of disease. The formulations are designed to prevent membrane degradation and maintain mitochondrial function proactively, rather than attempting to reverse advanced damage.

Inventive Principle:

Principle #10Preliminary action

Data Source

PatentUS11253531B2Lipid supplements for reducing nerve action potentials

Publication Date: 2022.02.22 NUTRITIONAL THERAPEUTICS

AI summary

A method of oral delivery of phospholipid/inulin compositions comprising capsules, tablets, chewable wafers or powdered material in a liquid carrier in quantities effective for treating pain from overactive neurons. The phospholipid/inulin compositions were also shown to be effective in reducing depression and intestinal malfunctions including, but not limited to, diarrhea and constipation, and improving sleep pattern. The compositions further including effective amounts of caffeine also reduces fatigue and enhances alertness and focus.